Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of BIOMEDICAL DIAGNOSTICS is 0.4% (very low). The company has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
10 mandates
7
active directors
Olivier BoscDirectorS.A. EUROBIO SCIENTIFICDirectorSTEENS MANAGEMENTDirector+7 in history
All directors & mandates Publicationslatest 26-11-2025
18
publications in the State GazetteAdriaan Ernon appointed as statutory auditorAll publications & acts Network & structure
13
connected companiesSee network & structure
Connections
13 connected companiesParent · 1 subsidiary · 1 location
Control→
via Fabienne STEENS · Permanent representative
former→
Trust signals
3 signalsLong-established
Founded in 2003 — 23 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.4%
Very low
0%0,5%1,5%4%10%≥25%
Long track record
−Lower-risk legal form
−Higher-failure-rate sector
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primary activity highlighted.
Names & trade names
| Legal nameNL | BIOMEDICAL DIAGNOSTICS |
| AbbreviationNL | BMD |
Registered office
Noorderlaan 139
2030 Antwerpen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.